Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - New York & Company, Inc.Financial_Report.xls
10-Q - 10-Q - New York & Company, Inc.a2212030z10-q.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R23.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R25.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R24.htm
XML - IDEA: XBRL DOCUMENT - New York & Company, Inc.R18.htm
EX-31.1 - EX-31.1 - New York & Company, Inc.a2212030zex-31_1.htm
EX-31.2 - EX-31.2 - New York & Company, Inc.a2212030zex-31_2.htm
EX-32.1 - EX-32.1 - New York & Company, Inc.a2212030zex-32_1.htm
v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Oct. 27, 2012
Oct. 29, 2011
Operating activities    
Net loss $ (8,380) $ (28,047)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 25,878 29,017
Loss from impairment charges 384 887
Amortization of deferred financing costs 89 148
Write-off of unamortized deferred financing costs   144
Share-based compensation expense 2,858 2,865
Changes in operating assets and liabilities:    
Accounts receivable (2,361) (48)
Income taxes receivable 11 57
Inventories, net (34,950) (38,722)
Prepaid expenses 74 151
Accounts payable 17,846 4,107
Accrued expenses (5,460) (17,823)
Income taxes payable (2,638) 2,518
Deferred rent (6,425) (7,810)
Other assets and liabilities (375) (1,110)
Net cash used in operating activities (13,449) (53,666)
Investing activities    
Capital expenditures (13,921) (9,367)
Net cash used in investing activities (13,921) (9,367)
Financing activities    
Proceeds from borrowings under revolving credit facility   12,000
Repayment of debt   (7,500)
Payment of financing costs   (393)
Proceeds from exercise of stock options 83 2,200
Net cash provided by financing activities 83 6,307
Net decrease in cash and cash equivalents (27,287) (56,726)
Cash and cash equivalents at beginning of period 50,787 77,392
Cash and cash equivalents at end of period $ 23,500 $ 20,666